LOS ANGELES, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Single-Use Bioprocessing Market is expected to witness significant growth in the coming years, driven by the expanding biopharmaceutical industry. Single-use bioprocessing technologies, which include disposable bioreactors, mixers, filters, tubing, and other products, offer numerous advantages such as reduced cross-contamination risks, faster changeover times, and simplified cleaning validation. This article provides in-depth insights into the market, encompassing the latest trends, growth drivers, challenges, regional analysis, and key companies operating in the single-use bioprocessing sector.
Single-Use Bioprocessing Market Highlights and Key Statistics:
- The Global Single-Use Bioprocessing Market Size is projected to reach USD 116.3 Billion by 2032, from the current capitalisation of USD 26.1 Billion by 2022, growing at a remarkable CAGR of 16.2% during the forecast period from 2023 to 2032.
- North America accounted for the largest share, exceeding 34%, in 2022, primarily owing to its well-established biopharmaceutical industry and high investments in research and development. The region's prominence in the market is further supported by the presence of key biopharma companies and contract manufacturing organizations (CMOs/CDMOs).
- Among the different single-use bioprocessing products available, media bags and containers commanded the dominant share of over 44% in 2022 due to their higher adoption rates.
- The increasing development of biologics including monoclonal antibodies as well as other therapeutic proteins, have gained significant importance in the pharmaceutical industry, leading to higher demand for single-use technologies.
Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/3295
Single-Use Bioprocessing Market Report Coverage:
| Market | Single-Use Bioprocessing Market | |
| Single-Use Bioprocessing Market Size 2022 | USD 26.1 Billion | |
| Single-Use Bioprocessing Market Forecast 2032 | USD 116.3 Billion | |
| Single-Use Bioprocessing Market CAGR During 2023 - 2032 | 16.2% | |
| Single-Use Bioprocessing Market Analysis Period | 2020 - 2032 | |
| Single-Use Bioprocessing Market Base Year | 2022 | |
| Single-Use Bioprocessing Market Forecast Data | 2023 - 2032 | |
| Segments Covered | By Product, By Workflow, By Application, By End User, And By Geography | |
| Single-Use Bioprocessing Market Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa | |
| Key Companies Profiled | Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA (MilliporeSigma), Eppendorf AG, Repligen Corporation, 3M Company, Entegris, Inc., Saint-Gobain Performance Plastics, Parker Hannifin Corporation, Avantor, Inc., and Meissner Filtration Products, Inc. | |
| Report Coverage | Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis | |
Single-Use Bioprocessing Market Overview and Analysis:
The outlook for the single-use bioprocessing market remains positive, driven by the continuous growth of the biopharmaceutical industry. The adoption of single-use bioprocessing technologies is propelled by the compelling benefits they offer, including reduced risk of cross-contamination, streamlined changeover processes, and faster turnaround times. Additionally, advancements in polymer materials have led to the development of single-use bioreactors that offer cell culture performance at par with stainless steel reactors, further fueling market expansion.
The high consumable costs associated with single-use technologies, however, remain a constraint for their widespread adoption. Manufacturers and biopharmaceutical companies need to carefully evaluate the cost-effectiveness of single-use bioprocessing solutions compared to the traditional stainless steel consumable equipment.
Latest Single-Use Bioprocessing Market Trends and Innovations:
Incorporation of sensors and advanced process control automation enhances the monitoring and control of single-use bioprocessing systems, ensuring optimized performance and product quality.
Design innovations in bags, tubing, connectors, and bioreactor geometries continue to improve the efficiency and ease of use of single-use bioprocessing products.
The adoption of single-use technologies for viral vector and gene therapy production is gaining momentum, driven by the rapid growth of gene-based therapeutics.
Offering integrated single-use assemblies and complete solutions simplifies adoption and implementation for biopharmaceutical manufacturers, streamlining their production processes.
Strategic partnerships between biopharma companies and single-use vendors foster collaboration and promote the development of innovative single-use bioprocessing solutions.
Single-Use Bioprocessing Market Major Growth Factors:
Rising pharmaceutical research and development investments and the increasing number of new product approvals create a strong demand for single-use bioprocessing solutions.
The outsourcing of bioproduction to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) is driving capacity expansion and the adoption of single-use technologies.
Single-use bioprocessing technologies offer higher yield and product quality through better process control, attracting manufacturers looking to optimize their production processes.
The faster implementation and reduced validation requirements of single-usage systems enable quicker responses to the production of new therapies and meet market demands promptly.
Increased production agility provided by single-use bioprocessing solutions allows biopharmaceutical companies to respond swiftly to emerging therapeutic needs and market dynamics.
Key Challenges in the Single-Use Bioprocessing Market:
Premium pricing of single-use consumables compared to the traditional stainless steel consumable equipment may pose financial challenges for some manufacturers.
Plastic waste generation from single-use consumables requires investments in recycling infrastructure to address environmental concerns.
Concerns regarding extractable and leachable contaminants from single-use materials remain a topic of consideration for manufacturers and regulators.
The requirement for storage space for spare single-use consumables can increase facility costs, particularly for large-scale bioproduction facilities.
The lack of standardization around the optimal selection of plastic resins for single-use bioprocessing materials may lead to variations in performance and compatibility.
Check the detailed table of contents of the report @
https://www.acumenresearchandconsulting.com/table-of-content/single-use-bioprocessing-market
Single-Use Bioprocessing Market Segmentation:
Based on Products
- Filtration Assembly type
- Media Bags and Container type
- Disposable Mixer type
- Disposable Bioreactor type
- Other type of products
Based on Workflows
- Upstream
- Fermentation
- Downstream
Based on Applications
- Purification
- Cell Culture
- Filtration
- Other
Based on End Users
- Clinical and Academic Research Institute
- Biopharmaceutical Manufacturer
- Other
Regional Analysis of the Single-Use Bioprocessing Market:
North America is expected to retain its dominant position in the global single-use bioprocessing market through 2032. The region's well-established biopharma industry, coupled with substantial investment in R&D, drives market growth. On the other hand, the Asia Pacific region is anticipated to exhibit the fastest growth in the single-use bioprocessing market. The region's growing biopharmaceutical sector, improving healthcare infrastructure, and the availability of skilled workforce contribute to this accelerated growth trajectory.
Buy this premium research report –
https://www.acumenresearchandconsulting.com/buy-now/0/3295
Major Companies in the Global Single-Use Bioprocessing Market:
Leading players operating in the Single-Use Bioprocessing Market include Danaher Corporation, Thermo Fisher Scientific, Sartorius Stedim Biotech S.A., Merck Millipore, GE Healthcare, Avantor Inc., Parker Hannifin Corporation, Saint-Gobain, Corning Incorporated, and others. These companies play a crucial role in driving innovation, research, and product development in the field of single-use bioprocessing, providing biopharmaceutical manufacturers with cutting-edge solutions to meet their production needs.
Browse More Research Topic on Automotive Industries Related Reports:
The Global Autologous Cell Therapy Market Size accounted for USD 6.1 Billion in 2022 and is projected to achieve a market size of USD 34.8 Billion by 2032 growing at a CAGR of 19.1% from 2023 to 2032.
The Global Behavioral Therapy Market Size accounted for USD 143.7 Billion in 2022 and is projected to achieve a market size of USD 308.8 Billion by 2032 growing at a CAGR of 8.1% from 2023 to 2032.
The Global Cold Laser Therapy Market Size accounted for USD 113.3 Million in 2022 and is projected to achieve a market size of USD 170.3 Million by 2032 growing at a CAGR of 4.3% from 2023 to 2032.
Browse Our Official Website Press release:
https://www.acumenresearchandconsulting.com/press-releases/single-use-bioprocessing-market
About Acumen Research and Consulting:
Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
For Latest Update Follow Us on Twitter , Instagram and LinkedIn
Contact Us:
Mr. Richard Johnson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533
E-mail: sales@acumenresearchandconsulting.com
